C

Centessa Pharmaceuticals plc
D

CNTA

12.480
USD
-0.24
(-1.89%)
مغلق
حجم التداول
22,466
الربح لكل سهم
-2
العائد الربحي
-
P/E
-7
حجم السوق
1,667,562,300
أصول ذات صلة
CRM
CRM
1.15
(0.44%)
260.64 USD
HUBS
HUBS
-9.56
(-1.76%)
534.58 USD
NOW
NOW
-10.73
(-1.09%)
970.48 USD
ORCL
ORCL
-5.520
(-2.62%)
205.180 USD
S
SCOR
-0.40000
(-7.91%)
4.66000 USD
TWLO
TWLO
-0.180
(-0.15%)
116.490 USD
WDAY
WDAY
1.285
(0.54%)
238.145 USD
ZS
ZS
-2.47
(-0.81%)
302.97 USD
المزيد
الأخبار المقالات

العنوان: Centessa Pharmaceuticals plc

القطاع: Healthcare
الصناعة: Biotechnology
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.